InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. Massive losses of -46.57% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - | - |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % | 57,85 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % | 84,82 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % | 54,81 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % | 64,03 % |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Invivo Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading InVivo Therapeutics Holdings
Buy beendet

